Isatuximab SAR650984
EFC12522
Phase 3 small_molecule active
Quick answer
Isatuximab SAR650984 for Plasma Cell Myeloma is a Phase 3 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Plasma Cell Myeloma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active